Yahoo
XETRA - Delayed Quote EUR

Gerresheimer AG (GXI.DE)

27.90 +0.52 (+1.90%)
At close: September 2 at 5:35:28 PM GMT+2
Chart Range Bar
Loading chart for GXI.DE
  • Previous Close 27.38
  • Open 27.30
  • Bid 28.14 x 21100
  • Ask 28.14 x 8200
  • Day's Range 26.86 - 28.70
  • 52 Week Range 14.83 - 44.80
  • Volume 213,320
  • Avg. Volume 189,004
  • Market Cap (intraday) 963.666M
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) --
  • EPS (TTM) -9.27
  • Earnings Date (est.) Sep 16, 2026
  • Forward Dividend & Yield 0.04 (0.15%)
  • Ex-Dividend Date Jun 6, 2025
  • 1y Target Est 27.38

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

www.gerresheimer.com

13,528

Full Time Employees

November 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 9/2/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

GXI.DE
1.16%
DAX P (^GDAXI)
5.51%

1-Year Return

GXI.DE
35.86%
DAX P (^GDAXI)
10.01%

3-Year Return

GXI.DE
76.77%
DAX P (^GDAXI)
63.12%

5-Year Return

GXI.DE
68.18%
DAX P (^GDAXI)
63.12%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 639.49M
Earnings -306.62M
Profit Margin -47.95%

Q2

FY25

Q4

FY25

-200M
0
200M
400M
600M
-40.0%
-30.0%
-20.0%
-10.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

20.00 Low
27.38 Average
27.90 Current
46.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 7/31/2026
  • Market Cap

    945.71M

  • Enterprise Value

    2.93B

  • Trailing P/E

    42.76

  • Forward P/E

    9.91

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.41

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    10.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.80%

  • Return on Assets (ttm)

    1.59%

  • Return on Equity (ttm)

    -24.41%

  • Revenue (ttm)

    2.32B

  • Net Income Avi to Common (ttm)

    -320.32M

  • Diluted EPS (ttm)

    -9.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    176.21M

  • Total Debt/Equity (mrq)

    207.98%

  • Levered Free Cash Flow (ttm)

    -425.33M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: